Copyright Reports & Markets. All rights reserved.

Europe Facial Injectables Market Report 2018

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Facial Injectables Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Botulinum Toxin Market Performance (Volume)
      • 2.1.2 Hyaluronic Acid Market Performance (Volume)
      • 2.1.3 Collagen Market Performance (Volume)
      • 2.1.4 Particle & Polymer Fillers (PPF) Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.1.1 Botulinum Toxin Market Performance (Value)
      • 2.1.2 Hyaluronic Acid Market Performance (Value)
      • 2.1.3 Collagen Market Performance (Value)
      • 2.1.4 Particle & Polymer Fillers (PPF) Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Hospitals Market Performance (Volume)
      • 3.1.2 Ambulatory Surgical Centers Market Performance (Volume)
      • 3.1.3 Cosmetic Centers Market Performance (Volume)
      • 3.1.4 Dermatology Clinics Market Performance (Volume)
      • 3.1.5 Physician Clinics Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Allergan
      • 4.1.1 Allergan Profiles
      • 4.1.2 Allergan Product Information
      • 4.1.3 Allergan Facial Injectables Business Performance
      • 4.1.4 Allergan Facial Injectables Business Development and Market Status
    • 4.2 Prollenium Medical Technologies Inc
      • 4.2.1 Prollenium Medical Technologies Inc Profiles
      • 4.2.2 Prollenium Medical Technologies Inc Product Information
      • 4.2.3 Prollenium Medical Technologies Inc Facial Injectables Business Performance
      • 4.2.4 Prollenium Medical Technologies Inc Facial Injectables Business Development and Market Status
    • 4.3 Galderma
      • 4.3.1 Galderma Profiles
      • 4.3.2 Galderma Product Information
      • 4.3.3 Galderma Facial Injectables Business Performance
      • 4.3.4 Galderma Facial Injectables Business Development and Market Status
    • 4.4 Merz Aesthetics
      • 4.4.1 Merz Aesthetics Profiles
      • 4.4.2 Merz Aesthetics Product Information
      • 4.4.3 Merz Aesthetics Facial Injectables Business Performance
      • 4.4.4 Merz Aesthetics Facial Injectables Business Development and Market Status
    • 4.5 Ipsen Group
      • 4.5.1 Ipsen Group Profiles
      • 4.5.2 Ipsen Group Product Information
      • 4.5.3 Ipsen Group Facial Injectables Business Performance
      • 4.5.4 Ipsen Group Facial Injectables Business Development and Market Status
    • 4.6 Bloomage BioTechnology
      • 4.6.1 Bloomage BioTechnology Profiles
      • 4.6.2 Bloomage BioTechnology Product Information
      • 4.6.3 Bloomage BioTechnology Facial Injectables Business Performance
      • 4.6.4 Bloomage BioTechnology Facial Injectables Business Development and Market Status
    • 4.7 Hangzhou Techderm Biological Products
      • 4.7.1 Hangzhou Techderm Biological Products Profiles
      • 4.7.2 Hangzhou Techderm Biological Products Product Information
      • 4.7.3 Hangzhou Techderm Biological Products Facial Injectables Business Performance
      • 4.7.4 Hangzhou Techderm Biological Products Facial Injectables Business Development and Market Status
    • 4.8 Laboratory Obvieline
      • 4.8.1 Laboratory Obvieline Profiles
      • 4.8.2 Laboratory Obvieline Product Information
      • 4.8.3 Laboratory Obvieline Facial Injectables Business Performance
      • 4.8.4 Laboratory Obvieline Facial Injectables Business Development and Market Status
    • 4.9 Medytox
      • 4.9.1 Medytox Profiles
      • 4.9.2 Medytox Product Information
      • 4.9.3 Medytox Facial Injectables Business Performance
      • 4.9.4 Medytox Facial Injectables Business Development and Market Status
    • 4.10 Polymekon
      • 4.10.1 Polymekon Profiles
      • 4.10.2 Polymekon Product Information
      • 4.10.3 Polymekon Facial Injectables Business Performance
      • 4.10.4 Polymekon Facial Injectables Business Development and Market Status
    • 4.11 Qufu Guanglong Biochem
    • 4.12 Revitacare
    • 4.13 Galderma
    • 4.14 Merz Aesthetics
    • 4.15 Ipsen Group

    5 Market Performance for Manufacturers

    • 5.1 Europe Facial Injectables Sales (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 Europe Facial Injectables Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 Europe Facial Injectables Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 Europe Facial Injectables Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 Germany Market Performance for Manufacturers
      • 6.1.1 Germany Facial Injectables Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.1.2 Germany Facial Injectables Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.1.3 Germany Facial Injectables Price (USD/Unit) of Manufacturers 2013-2018
      • 6.1.4 Germany Facial Injectables Gross Margin of Manufacturers 2013-2018
      • 6.1.5 Market Concentration
    • 6.2 UK Market Performance for Manufacturers
      • 6.2.1 UK Facial Injectables Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.2.2 UK Facial Injectables Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.2.3 UK Facial Injectables Price (USD/Unit) of Manufacturers 2013-2018
      • 6.2.4 UK Facial Injectables Gross Margin of Manufacturers 2013-2018
      • 6.2.5 Market Concentration
    • 6.3 France Market Performance for Manufacturers
      • 6.3.1 France Facial Injectables Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.3.2 France Facial Injectables Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.3.3 France Facial Injectables Price (USD/Unit) of Manufacturers 2013-2018
      • 6.3.4 France Facial Injectables Gross Margin of Manufacturers 2013-2018
      • 6.3.5 Market Concentration
    • 6.4 Russia Market Performance for Manufacturers
      • 6.4.1 Russia Facial Injectables Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.4.2 Russia Facial Injectables Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.4.3 Russia Facial Injectables Price (USD/Unit) of Manufacturers 2013-2018
      • 6.4.4 Russia Facial Injectables Gross Margin of Manufacturers 2013-2018
      • 6.4.5 Market Concentration
    • 6.5 Benelux Market Performance for Manufacturers
      • 6.5.1 Benelux Facial Injectables Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.5.2 Benelux Facial Injectables Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.5.3 Benelux Facial Injectables Price (USD/Unit) of Manufacturers 2013-2018
      • 6.5.4 Benelux Facial Injectables Gross Margin of Manufacturers 2013-2018
      • 6.5.5 Market Concentration
    • 6.6 Italy Market Performance for Manufacturers
      • 6.6.1 Italy Facial Injectables Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.6.2 Italy Facial Injectables Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.6.3 Italy Facial Injectables Price (USD/Unit) of Manufacturers 2013-2018
      • 6.6.4 Italy Facial Injectables Gross Margin of Manufacturers 2013-2018
      • 6.6.5 Market Concentration
    • 6.7 Spain Market Performance for Manufacturers
      • 6.7.1 Spain Facial Injectables Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.7.2 Spain Facial Injectables Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.7.3 Spain Facial Injectables Price (USD/Unit) of Manufacturers 2013-2018
      • 6.7.4 Spain Facial Injectables Gross Margin of Manufacturers 2013-2018
      • 6.7.5 Market Concentration
    • 6.8 Market Performance for Manufacturers
      • 6.8.1 Facial Injectables Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.8.2 Facial Injectables Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.8.3 Facial Injectables Price (USD/Unit) of Manufacturers 2013-2018
      • 6.8.4 Facial Injectables Gross Margin of Manufacturers 2013-2018
      • 6.8.5 Market Concentration

    7 Europe Facial Injectables Market Performance (Sales Point)

    • 7.1 Europe Facial Injectables Sales (K Units) and Market Share by Regions 2013-2018
    • 7.2 Europe Facial Injectables Revenue (M USD) and Market Share by Regions 2013-2018
    • 7.3 Europe Facial Injectables Price (USD/Unit) by Regions 2013-2018
    • 7.4 Europe Facial Injectables Gross Margin by Regions 2013-2018

    8 Development Trend for Regions (Sales Point)

    • 8.1 Europe Facial Injectables Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.2 Germany Facial Injectables Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.3 UK Facial Injectables Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.4 France Facial Injectables Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.5 Russia Facial Injectables Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.6 Benelux Facial Injectables Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.7 Italy Facial Injectables Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Spain Facial Injectables Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Spain Facial Injectables Sales and Growth, Sales Value and Growth Rate2013-2018

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Hospitals Industry
    • 11.2 Ambulatory Surgical Centers Industry
    • 11.3 Cosmetic Centers Industry

    12 Market Forecast 2019-2024

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 12.1.1 Europe Facial Injectables Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 12.1.2 Europe Facial Injectables Sales (K Units) and Growth Rate 2019-2024
      • 12.1.3 Germany Facial Injectables Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.4 UK Facial Injectables Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.5 France Facial Injectables Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.6 Russia Facial Injectables Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.7 Benelux Facial Injectables Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.8 Italy Facial Injectables Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.9 Spain Facial Injectables Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
      • 12.3.1 Overall Market Performance
      • 12.3.2 Botulinum Toxin Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.3 Hyaluronic Acid Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.4 Collagen Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.5 Particle & Polymer Fillers (PPF) Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.4 Sales by Application 2019-2024
      • 12.4.1 Overall Market Performance
      • 12.4.2 Hospitals Sales and and Growth Rate 2019-2024
      • 12.4.3 Ambulatory Surgical Centers Sales and and Growth Rate 2019-2024
      • 12.4.4 Cosmetic Centers Sales and and Growth Rate 2019-2024
      • 12.4.5 Dermatology Clinics Sales and and Growth Rate 2019-2024
    • 12.5 Price (USD/Unit) and Gross Profit
      • 12.5.1 Europe Facial Injectables Price (USD/Unit) Trend 2019-2024
      • 12.5.2 Europe Facial Injectables Gross Profit Trend 2019-2024

    13 Conclusion

    Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Facial Injectables for these regions, from 2012 to 2023 (forecast), including
    Germany
    UK
    France
    Russia
    Benelux
    Italy
    Spain

    Europe Facial Injectables market competition by top manufacturers/players, with Facial Injectables sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Allergan
    Prollenium Medical Technologies Inc
    Galderma
    Merz Aesthetics
    Ipsen Group
    Bloomage BioTechnology
    Hangzhou Techderm Biological Products
    Laboratory Obvieline
    Medytox
    Polymekon
    Qufu Guanglong Biochem
    Revitacare
    Suneva Medical
    SciVision Biotech
    Speciality European Pharma

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Botulinum Toxin
    Hyaluronic Acid
    Collagen
    Particle & Polymer Fillers (PPF)

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Facial Injectables for each application, including
    Hospitals
    Ambulatory Surgical Centers
    Cosmetic Centers
    Dermatology Clinics
    Physician Clinics

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now